NASDAQ
Clinuvel Pharmaceuticals Limited (CLVLY) has a interest coverage ratio of 10.25x as of Friday, May 29, 2026. This represents a 24.97% decrease compared to its 12-month average of 13.66x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.